Chinese expert consensus on nutritional management of prostate cancer in the era of precision medicine
-
摘要: 前列腺癌发病率逐年上升，居泌尿男生殖系统肿瘤首位。研究显示，前列腺癌发病与膳食因素相关。晚期前列腺癌需要长期接受内分泌治疗，其并发症需要进行综合的营养治疗。但是，目前我国没有前列腺癌营养管理相关的指南和标准规范。本共识组查看国内外最新的前列腺癌营养管理相关的研究证据、指南与标准，通过专家讨论，制定《精准医学时代前列腺癌营养管理中国专家共识》，给临床医师和营养师以参考，帮助前列腺癌患者做好自我营养管理，促进康复和改善生活质量。Abstract: The incidence of prostate cancer has been increasing year by year, ranking first among tumors in the urinary and male genital systems. Research indicates that the occurrence of prostate cancer is associated with dietary factors. Patients with advanced prostate cancer need to receive long-term endocrine therapy, and comprehensive nutritional therapy is required for its complications. However, currently, there are no standardized guidelines or national standards for nutrition management in prostate cancer patients in China. This consensus group examined the latest research evidence, guidelines and standards related to nutrition management in prostate cancer both at home and abroad. Through expert discussions, the "Chinese expert consensus on nutritional management of prostate cancer in the era of precision medicine" was developed to serve as reference for clinicians and dietitians, assisting prostate cancer patients in effective self-nutrition management, promoting rehabilitation and improving the quality of life.
-
Key words:
- prostate cancer /
- precision medicine /
- nutrition management /
- expert consensus
-
-
[1] 国家卫生健康委. 中国居民营养与慢性病状况报告-2020年[M]. 北京: 人民卫生出版社, 2021.
[2] 李星, 曾晓勇. 中国前列腺癌流行病学研究进展[J]. 肿瘤防治研究, 2021, 48(1): 98-102. doi: 10.3971/j.issn.1000-8578.2021.20.0370
[3] 中国抗癌协会男性生殖系统肿瘤专业委员会. 高危前列腺癌围手术期综合治疗专家共识(2023年版)[J]. 中国癌症杂志, 2023, 33(12): 1204-1216.
[4] 中国抗癌协会泌尿男生殖系统肿瘤专业委员会前列腺癌学组. 前列腺癌筛查专家共识[J]. 中华外科杂志, 2017, 55(5): 340-342. doi: 10.3760/cma.j.issn.0529-5815.2017.05.005
[5] 中国抗癌协会肿瘤营养专业委员会, 中华医学会肠外肠内营养学分会. 前列腺癌患者的营养治疗专家共识[J]. 肿瘤代谢与营养电子杂志, 2021, 8(5): 503-507.
[6] 中华医学会泌尿外科学分会, 中国前列腺癌联盟. 中国前列腺癌药物去势治疗专家共识[J]. 中华泌尿外科杂志, 2016, 37(7): 481-484. doi: 10.3760/cma.j.issn.1000-6702.2016.07.001
[7] Bargiota A, Oeconomou A, Zachos I, et al. Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on muscle and bone health[J]. J BUON, 2020, 25(3): 1286-1294.
[8] Hartrampf PE, Mihatsch PW, Seitz AK, et al. Elevated body mass index is associated with improved overall survival in castration-resistant prostate cancer patients undergoing prostate-specific membrane antigen-directed radioligand therapy[J]. J Nucl Med, 2023, 64(8): 1272-1278. doi: 10.2967/jnumed.122.265379
[9] Khodadadi S, Sobhani N, Mirshekar S, et al. Tumor cells growth and survival time with the ketogenic diet in animal models: a systematic review[J]. Int J Prev Med, 2017, 8: 35. doi: 10.4103/2008-7802.207035
[10] Okechukwu CE. Cross talk between the ketogenic diet and metastatic prostate cancer cells[J]. World J Mens Health, 2022, 40(1): 162-163. doi: 10.5534/wjmh.210020
[11] Lin PH, Aronson W, Freedland SJ. An update of research evidence on nutrition and prostate cancer[J]. Urol Oncol, 2019, 37(6): 387-401. doi: 10.1016/j.urolonc.2017.10.006
[12] Matsushita M, Fujita K, Hatano K, et al. Emerging relationship between the gut microbiome and prostate cancer[J]. World J Mens Health, 2023, 41(4): 759-768. doi: 10.5534/wjmh.220202
[13] Fujita K, Matsushita M, Banno E, et al. Gut microbiome and prostate cancer[J]. Int J Urol, 2022, 29(8): 793-798. doi: 10.1111/iju.14894
[14] 中国营养学会. 中国居民膳食营养素参考摄入量: 2023版[M]. 北京: 人民卫生出版社, 2023.
[15] Pandit P, Shirke C, Bhatia N, et al. An overview of recent findings that shed light on the connection between fat and cancer[J]. Endocr Metab Immune Disord Drug Targets, 2024, 24(2): 178-193. doi: 10.2174/1871530323666230724141942
[16] Labbé DP, Zadra G, Yang M, et al. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program[J]. Nat Commun, 2019, 10(1): 4358. doi: 10.1038/s41467-019-12298-z
[17] Matsushita M, Fujita K, Hatano K, et al. High-fat diet promotes prostate cancer growth through histamine signaling[J]. Int J Cancer, 2022, 151(4): 623-636. doi: 10.1002/ijc.34028
[18] Heinze VM, Actis AB. Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: a review[J]. Int J Food Sci Nutr, 2012, 63(1): 66-78. doi: 10.3109/09637486.2011.598849
[19] Hackshaw-McGeagh LE, Penfold C, Shingler E, et al. Phase Ⅱ randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer[J]. BMJ Open, 2019, 9(11): e029480. doi: 10.1136/bmjopen-2019-029480
[20] Bylsma LC, Alexander DD. A review and meta-analysis of prospective studies of red and processed meat, meat cooking methods, heme iron, heterocyclic amines and prostate cancer[J]. Nutr J, 2015, 14: 125. doi: 10.1186/s12937-015-0111-3
[21] Cicero AFG, Allkanjari O, Busetto GM, et al. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer[J]. Arch Ital Urol Androl, 2019, 91(3).
[22] Vasconcelos A, Santos T, Ravasco P, et al. Dairy products: is there an impact on promotion of prostate cancer? A review of the literature[J]. Front Nutr, 2019, 6: 62. doi: 10.3389/fnut.2019.00062
[23] Zhao ZF, Wu DH, Gao SR, et al. The association between dairy products consumption and prostate cancer risk: a systematic review and meta-analysis[J]. Br J Nutr, 2023, 129(10): 1714-1731. doi: 10.1017/S0007114522002380
[24] Doldo E, Costanza G, Agostinelli S, et al. Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins[J]. Biomed Res Int, 2015, 2015: 624627.
[25] Loh WQ, Yin X, Kishida R, et al. Association between vitamin A and E forms and prostate cancer risk in the Singapore prostate cancer study[J]. Nutrients, 2023, 15(12): 2677. doi: 10.3390/nu15122677
[26] Cassell A, Konneh S. Unlocking the potential-vitamin D in prostate cancer prevention[J]. World J Clin Oncol, 2024, 15(2): 169-174.
[27] Trump DL, Aragon-Ching JB. Vitamin D in prostate cancer[J]. Asian J Androl, 2018, 20(3): 244-252. doi: 10.4103/aja.aja_14_18
[28] Schenk JM, Till C, Neuhouser ML, et al. Differential biopsy patterns influence associations between multivitamin use and prostate cancer risk in the selenium and vitamin E cancer prevention trial[J]. Cancer Epidemiol Biomarkers Prev, 2022, 31(11): 2063-2069. doi: 10.1158/1055-9965.EPI-22-0453
[29] Loh WQ, Youn J, Seow WJ. Vitamin E intake and risk of prostate cancer: a meta-analysis[J]. Nutrients, 2022, 15(1): 14. doi: 10.3390/nu15010014
[30] Orlich MJ, Mashchak AD, Jaceldo-Siegl K, et al. Dairy foods, calcium intakes, and risk of incident prostate cancer in Adventist Health Study-2[J]. Am J Clin Nutr, 2022, 116(2): 314-324. doi: 10.1093/ajcn/nqac093
[31] Rahmati S, Azami M, Delpisheh A, et al. Total calcium(dietary and supplementary)intake and prostate cancer: a systematic review and meta-analysis[J]. Asian Pac J Cancer Prev, 2018, 19(6): 1449-1456.
[32] Vinceti M, Filippini T, Wise LA. Environmental selenium and human health: an update[J]. Curr Environ Health Rep, 2018, 5(4): 464-485. doi: 10.1007/s40572-018-0213-0
[33] Vinceti M, Filippini T, Del Giovane C, et al. Selenium for preventing cancer[J]. Cochrane Database Syst Rev, 2018, 1(1): CD005195.
[34] Jiang JJ, Chen B, Tang B, et al. Selenium in prostate cancer: prevention, progression, and treatment[J]. Pharmaceuticals(Basel), 2023, 16(9): 1250. doi: 10.3390/ph16091250
[35] Ajdžanovic V, Šošic-Jurjevic B, Vodnik V, et al. Interventions on soy isoflavone molecules to improve their therapeutic potential for prostate cancer treatment[J]. EXCLI J, 2022, 21: 941-947.
[36] Dong X, Xu WQ, Sikes RA, et al. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone[J]. Food Chem, 2013, 141(3): 1923-1933.
[37] Lilly MB, Wu CL, Ke Y, et al. A phase Ⅰ study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients[J]. Clin Transl Med, 2024, 14(3): e1627. doi: 10.1002/ctm2.1627
[38] Khalaf RA, Awad M. Lycopene as a potential bioactive compound: chemistry, extraction, and anticancer prospective[J]. Curr Cancer Drug Targets, 2023, 23(8): 634-642. doi: 10.2174/1568009623666230131124236
[39] Puah BP, Jalil J, Attiq A, et al. New insights into molecular mechanism behind anti-cancer activities of lycopene[J]. Molecules, 2021, 26(13): 3888. doi: 10.3390/molecules26133888
[40] Scarpitti BT, Chitchumroonchokchai C, Clinton SK, et al. In vitro imaging of lycopene delivery to prostate cancer cells[J]. Anal Chem, 2022, 94(12): 5106-5112. doi: 10.1021/acs.analchem.1c05442
[41] Bosland MC, Horton L, Condon MS. Effects of green tea on prostate carcinogenesis in rat models and a human prostate cancer xenograft model[J]. Prostate, 2022, 82(11): 1117-1124. doi: 10.1002/pros.24364
[42] Guo YM, Zhi F, Chen P, et al. Green tea and the risk of prostate cancer: a systematic review and meta-analysis[J]. Medicine(Baltimore), 2017, 96(13): e6426.
[43] 中国营养学会. 中国居民膳食指南-2022[M]. 北京: 人民卫生出版社, 2022.
[44] Vecchia CL, Chatenoud L, Negri E, et al. Session: whole cereal grains, fibre and human cancer wholegrain cereals and cancer in Italy[J]. Proc Nutr Soc, 2003, 62(1): 45-49. doi: 10.1079/PNS2002235
[45] Lee KH, Seong HJ, Kim G, et al. Consumption of fish and ω-3 fatty acids and cancer risk: an umbrella review of meta-analyses of observational studies[J]. Adv Nutr, 2020, 11(5): 1134-1149. doi: 10.1093/advances/nmaa055
[46] López-Plaza B, Bermejo LM, Santurino C, et al. Milk and dairy product consumption and prostate cancer risk and mortality: an overview of systematic reviews and meta-analyses[J]. Adv Nutr, 2019, 10(suppl_2): S212-S223.
[47] Thorning TK, Raben A, Tholstrup T, et al. Milk and dairy products: good or bad for human health? An assessment of the totality of scientific evidence[J]. Food Nutr Res, 2016, 60: 32527. doi: 10.3402/fnr.v60.32527
[48] Vue B, Zhang S, Chen QH. Synergistic effects of dietary natural products as anti-prostate cancer agents[J]. Nat Prod Commun, 2015, 10(12): 2179-2188.
[49] Zandieh MA, Farahani MH, Daryab M, et al. Stimuli-responsive(nano)architectures for phytochemical delivery in cancer therapy[J]. Biomed Pharmacother, 2023, 166: 115283. doi: 10.1016/j.biopha.2023.115283
[50] Gano CA, Fatima S, Failes TW, et al. Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines[J]. Front Nutr, 2023, 10: 1119274. doi: 10.3389/fnut.2023.1119274
[51] Fattahian M, Ghanadian M, Zolfaghari B, et al. Phytochemical analysis of Artemisia kopetdaghensis: sesquiterpene lactones with proapoptotic activity against prostate cancer cells[J]. Phytochemistry, 2022, 203: 113411. doi: 10.1016/j.phytochem.2022.113411
[52] Wu SX, Xiong RG, Huang SY, et al. Effects and mechanisms of resveratrol for prevention and management of cancers: an updated review[J]. Crit Rev Food Sci Nutr, 2023, 63(33): 12422-12440.
[53] Wang MH, Jian ZY, Yuan C, et al. Coffee consumption and prostate cancer risk: results from national health and nutrition examination survey 1999-2010 and mendelian randomization analyses[J]. Nutrients, 2021, 13(7): 2317.
[54] Loeb S, Fu BC, Bauer SR, et al. Association of plant-based diet index with prostate cancer risk[J]. Am J Clin Nutr, 2022, 115(3): 662-670.
[55] Seyfried TN. The effects of diet on prostate cancer outcomes[J]. Nat Rev Urol, 2022, 19(7): 389-390.
[56] Wilson RL, Taaffe DR, Newton RU, et al. Obesity and prostate cancer: a narrative review[J]. Crit Rev Oncol Hematol, 2022, 169: 103543.
[57] 中国营养学会膳食指南工作委员会. 膳食指南科学证据和方法学研究[M]. 北京: 人民卫生出版社, 2019.
[58] 中华医学会肠外肠内营养学分会. 中国成人患者肠外肠内营养临床应用指南(2023版)[J]. 中华医学杂志, 2023, 103(13): 946-974.
[59] Cao JR, Liu W, Luo QS, et al. Investigation on the 3-step procedure of nutritional screening, evaluation, and GLIM diagnosis for elderly inpatients[J]. Top Clin Nutr, 2023, 38(3): 239-248.
[60] 许静涌, 杨剑, 康维明, 等. 营养风险及营养风险筛查工具营养风险筛查2002临床应用专家共识(2018版)[J]. 中华临床营养杂志, 2018, 26(3): 131-135.
[61] 医学名词审定委员会肠外肠内营养学名词审定分委员会. 肠外肠内营养学名词[M]. 北京: 科学出版社, 2019.
[62] Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002[J]. Clin Nutr, 2003, 22(4): 415-421.
[63] 王乔宇, 赵志刚. 2017版《国家基本医疗保险、工伤保险和生育保险的药品目录》与旧版目录的对比及思考[J]. 药品评价, 2017, 14(20): 8-18, 29.
[64] Wunderle C, Gomes F, Schuetz P, et al. ESPEN guideline on nutritional support for polymorbid medical inpatients[J]. Clin Nutr, 2023, 42(9): 1545-1568.
[65] Singer P, Blaser AR, Berger MM, et al. ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit[J]. Clin Nutr, 2023, 42(9): 1671-1689.
[66] Henriksen C, Paur I, Pedersen A, et al. Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM[J]. Clin Nutr, 2022, 41(2): 329-336.
[67] Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition[J]. Clin Nutr, 2017, 36(1): 49-64.
[68] Huo ZY, Chong FF, Yin LY, et al. Accuracy of the GLIM criteria for diagnosing malnutrition: a systematic review and meta-analysis[J]. Clin Nutr, 2022, 41(6): 1208-1217.
[69] Correia MITD, Tappenden KA, Malone A, et al. Utilization and validation of the global leadership initiative on malnutrition(GLIM): a scoping review[J]. Clin Nutr, 2022, 41(3): 687-697.
[70] Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition-A consensus report from the global clinical nutrition community[J]. Clin Nutr, 2019, 38(1): 1-9.
[71] 中华医学会肠外肠内营养学分会. 成人围手术期营养支持指南[J]. 中华外科杂志, 2016, 54(9): 641-657.
[72] 于康. 临床营养支持治疗[M]. 3版. 北京: 中国协和医科大学出版社, 2021.
[73] 于健春. 临床肠外肠内营养治疗指南与共识[M]. 北京: 中华医学电子音像出版社, 2018.
[74] 中国抗癌协会肿瘤营养专业委员会, 中华医学会肠外肠内营养学分会组织. 中国肿瘤营养治疗指南-2020[M]. 北京: 人民卫生出版社, 2020.
[75] Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer[J]. J Urol, 2013, 189(1 Suppl): S34-42;discussion S43-4.
[76] Kova MB, Pavlin T, avka L, et al. The trajectory of sarcopenia following diagnosis of prostate cancer: a systematic review and meta-analysis[J]. J Geriatr Oncol, 2023, 14(7): 101594.
[77] Mafla-España MA, Torregrosa MD, Cauli O. Analysis of frailty syndrome in men with metastatic prostate cancer: a scoping review[J]. J Pers Med, 2023, 13(2): 319.
[78] de Pablos-Rodríguez P, Del Pino-Sedeño T, Infante-Ventura D, et al. Prognostic impact of sarcopenia in patients with advanced prostate carcinoma: a systematic review[J]. J Clin Med, 2022, 12(1): 57.
[79] Dent E, Lien C, Lim WS, et al. The Asia-Pacific clinical practice guidelines for the management of frailty[J]. J Am Med Dir Assoc, 2017, 18(7): 564-575.
[80] Cesari M, Calvani R, Marzetti E. Frailty in older persons[J]. Clin Geriatr Med, 2017, 33(3): 293-303.
[81] Bahat G, Tufan A, Tufan F, et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People(EWGSOP)definition[J]. Clin Nutr, 2016, 35(6): 1557-1563.
[82] Chen LK, Lee WJ, Peng LN, et al. Recent advances in sarcopenia research in Asia: 2016 update from the Asian working group for sarcopenia[J]. J Am Med Dir Assoc, 2016, 17(8): 767. e1-767. e7.
[83] Li R, Hu X, Tan L, et al. Screening for sarcopenia with a self-reported cartoon questionnaire: combining SARC-F with finger-ring test[J]. J Nutr Health Aging, 2020, 24(10): 1100-1106.
[84] Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction[J]. J Korean Med Sci, 2022, 37(18): e146.
[85] Calvani R, Picca A, Coelho-Júnior HJ, et al. Diet for the prevention and management of sarcopenia[J]. Metabolism, 2023, 146: 155637.
[86] Nishikawa H, Fukunishi S, Asai A, et al. Pathophysiology and mechanisms of primary sarcopenia(review)[J]. Int J Mol Med, 2021, 48(2): 156.
[87] Liu SM, Zhang L, Li SQ. Advances in nutritional supplementation for sarcopenia management[J]. Front Nutr, 2023, 10: 1189522.
[88] 中国抗癌协会肿瘤营养专业委员会. 肿瘤相关性肌肉减少症临床诊断与治疗指南[J]. 肿瘤代谢与营养电子杂志, 2022, 9(1): 24-34.
[89] Uchitomi R, Oyabu M, Kamei Y. Vitamin D and sarcopenia: potential of vitamin D supplementation in sarcopenia prevention and treatment[J]. Nutrients, 2020, 12(10): 3189.
[90] 黄宏兴, 史晓林, 李盛华, 等. 肌少-骨质疏松症专家共识[J]. 中国骨质疏松杂志, 2022, 28(11): 1561-1570.
[91] 崔华, 王朝晖, 吴剑卿, 等. 老年人肌少症防控干预中国专家共识(2023)[J]. 中华老年医学杂志, 2023, 42(2): 144-153.
[92] Nascimento CM, Ingles M, Salvador-Pascual A, et al. Sarcopenia, frailty and their prevention by exercise[J]. Free Radic Biol Med, 2019, 132: 42-49.
[93] 中国抗癌协会肿瘤营养专业委员会, 中国医疗保健国际交流促进会临床营养健康学分会, 李增宁. 老年肌肉减少症患者筛查诊断与营养干预指南[J]. 肿瘤代谢与营养电子杂志, 2024, 11(1): 45-55.
-
计量
- 文章访问数: 181
- 施引文献: 0
下载: